GEN Exclusives

More »

GEN News Highlights

More »
May 22, 2007

Dyax and Trubion Expand Research Alliance

  • Dyax and Trubion Pharmaceuticals have prolonged its existing research agreement, which covers protein therapeutics and diagnostics discovery.

    In addition to the ongoing multiple-target funded research project, Dyax will now transfer its phage library to Trubion’s facility for use in identifying therapeutic leads to additional targets. This will enhanceTrubion’s ability to rapidly design and develop product candidates for a range of disease targets.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »